What changed in this filing

/stocks — the workspaceLOADING

Item 1. Business

2023-12-20 compared with 2022-12-21 · 72 added, 73 removed, 423 unchanged (26% of the section changed)

2 unchanged sentences

For fiscal year ended October 31, 2023, we have three business segments comprised of the life sciences and applied markets business, the diagnostics and genomics business and the Agilent CrossLab business.

Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

Our life sciences and applied markets business provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

Our consumables portfolio is designed to improve customer outcomes.

6 unchanged sentences

As of October 31, 2023, we employed approximately 18,100 people worldwide.

Our primary research and development and manufacturing sites are in California, Colorado, Delaware, Massachusetts, Texas, Vermont and Washington in the U.S.

Our primary research and development and manufacturing sites are in California, Colorado, Delaware, Massachusetts, Texas and Vermont in the U.S.

and in Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore and the United Kingdom.

Life Sciences and Applied Markets Business

Key product categories include:

24 unchanged sentences

Life Sciences and Applied Markets

Our life sciences and applied markets business focuses primarily on the following five markets:

The Pharmaceutical, Biopharmaceutical, CRO & CMO Market.

23 unchanged sentences

There is also a significant food safety market involved in analyzing food for pathogen contamination, accurate verification of species type and evidence of genetically modified content.

The Diagnostics and Clinical Market.

The diagnostics and clinical market focus within our life sciences and applied markets business is to provide instruments, software, reagents, and consumables that enable customers performing life sciences, pharmaceutical and clinical research to interrogate biologically relevant metabolites, lipids, protein, and cellular systems to understand fundamental biological processes, as well as the underlying mechanisms of cancer and other disease initiation and progression.

The goal is to use this information to develop new therapeutic strategies and drugs as well as new diagnostic tests.

Our mass spectrometry technologies are employed by researchers to identify and quantify individual or whole classes of metabolites, lipids, or proteins involved in basic cellular processes and elucidate those which are quantitatively or qualitatively altered in disease states, as well as to identify those which may be useful as biomarkers for a disease.

Our Seahorse, xCELLigence, Novocyte, and BioTek platform technologies are used both stand-alone and in conjunction with mass spectrometry to understand underlying cellular physiology and interactions in normal and diseased states, as well to help understand how new drugs and therapies alter the composition, function, or interaction of cells.

In addition, our XCELLigence and Novocyte technologies can be used to characterize and quantify immune cell response (for example cytotoxicity).

Life Sciences and Applied Markets Products and Applications

20 unchanged sentences

Spectroscopy is a technique for analyzing the individual chemical components of substances based on the absorption or emission of electromagnetic radiation of specific wavelengths of light.

Our spectroscopy instruments include AA spectrometers, microwave plasma-atomic emission spectrometers ("MP-AES"), ICP-OES, ICP-MS, fluorescence spectrophotometers, ultraviolet-visible ("UV-Vis") spectrophotometers, Fourier Transform infrared ("FT-IR") spectrometers, near-infrared ("NIR") spectrometers, raman spectrometers and sample automation products.

spectrometers, raman spectrometers and sample automation products.

We also offer related software, accessories and consumable products for these and other similar instruments.

4 unchanged sentences

Laboratory Automation and Robotics

We offer a comprehensive suite of workflow solutions to our life science customers with the addition of automated liquid handling and robotics that range from standalone instrumentation to bench-top automation solutions.

These solutions strengthen our offering of automated sample preparation solutions across a broad range of applications.

We offer a portfolio of unique sample preparation automated solutions that are key to a comprehensive suite of workflow solutions to our life science customers.

This includes liquid handling, plate management, unique consumables and scheduling software with solutions that range from standalone instrumentation to bench-top automation solutions.

These solutions strengthen our offering of automated sample preparation across a broad range of applications which are integrated with several of our analytical and NGS platforms across the company.

Vacuum Technology

1 unchanged sentence

Vacuum technologies' customers are typically OEMs that manufacture equipment for these applications, or government and research organizations that require vacuum solutions in their facilities.

Products include a wide range of high and ultra-high vacuum pumps (diffusion, turbomolecular and ion getter), primary vacuum pumps (rotary vane and dry scroll), vacuum instrumentation (vacuum control instruments, sensor gauges and meters) and vacuum components (valves, flanges and other mechanical hardware).

Products include a wide range of high and ultra-high vacuum pumps (diffusion, turbo molecular and ion getter), primary vacuum pumps (rotary vane and dry scroll), vacuum instrumentation (vacuum control instruments, sensor gauges and meters) and vacuum components (valves, flanges and other mechanical hardware).

These products also include helium mass spectrometry and helium-sensing leak detection instruments used to identify and measure leaks in hermetic or vacuum environments.

4 unchanged sentences

Our cell analysis portfolio includes cell analysis plate-based assays, flow cytometer, real-time cell analyzer, microplate reader, cell imaging system and related consumables.

Cell analysis customers are typically academic institutions and pharma and biopharma companies.

Chemistries and Supplies

10 unchanged sentences

The life sciences and applied markets business is susceptible to seasonality in its orders and revenues primarily related to U.S.

and foreign government budgets, chemicals and advanced materials and environmental customers and large

pharmaceutical company budgets.

and foreign government budgets, chemicals and advanced materials and environmental customers and large pharmaceutical company budgets.

Historically, the result is that our first and fourth fiscal quarters tend to deliver the strongest profits for this group.

14 unchanged sentences

We selectively use third parties to provide some supply chain processes for manufacturing, warehousing and logistics.

Inside the U.S., we have manufacturing facilities in California, Delaware, Massachusetts and Vermont.

Outside of the U.S., we have manufacturing facilities in Germany, Malaysia and Singapore.

Inside the U.S., we have manufacturing facilities in California, Delaware, Massachusetts, Rhode Island and Vermont.

Outside of the U.S., we have manufacturing facilities in China, Germany, Italy, Malaysia, Netherlands, Singapore and the United Kingdom.

We have FDA registered sites in California, Vermont, Germany and Singapore.

4 unchanged sentences

and Waters Corporation.

Agilent competes on the basis of product performance, reliability, support quality, applications expertise, global channel coverage and price.

We compete on the basis of product performance, reliability, support quality, applications expertise, global channel coverage and price.

Diagnostics and Genomics Business

5 unchanged sentences

Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows.

The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&E") staining and special staining.

Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy.

The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin

("H&E") staining and special staining.

Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy.

Fifth, the reagent partnership business provides clinical flow cytometry reagents for routine cancer diagnostics.

13 unchanged sentences

Our products fall into eight main areas of work:

pathology products, specific proteins and flow cytometry reagents, companion diagnostics, target enrichment, cytogenetic research solutions and microarrays, PCR and qPCR instrumentation and molecular biology reagents, nucleic acid solutions and automated electrophoresis and microfluidics.

pathology products, specific proteins and flow cytometry reagents, companion diagnostics, target enrichment, cytogenetic research solutions and microarrays, qPCR instrumentation and molecular biology reagents, nucleic acid solutions and automated electrophoresis and microfluidics solutions.

This area consists of routine clinical solutions for tissue-based cancer diagnostics with solutions that comprise antibodies, reagents, instruments and software targeting both primary and advanced cancer diagnostics.

2 unchanged sentences

These products also include companion diagnostic tests that are used to help identify patients most likely to benefit from a specific targeted therapy.

Specific Proteins and Flow Cytometry Reagents

In these areas, we partner with IVD manufacturers, biotechnology and pharmaceutical companies by offering antibodies as raw materials and a range of associated assay development services and solutions.

Bulk Antibodies and Flow Cytometry Reagents

In our Bulk Antibodies business we partner with IVD manufacturers, biotechnology and pharmaceutical companies by offering antibodies as raw materials and a range of associated assay development services and solutions.

We operate in several areas of clinical relevance for the customers and address multiple technologies such as turbidimetry, gel techniques and chemiluminescence immunoassays.

9 unchanged sentences

These products are used for mutation detection and genotyping.

Results can be easily analyzed using Agilent’s Alissa software solutions.

Our solutions also enable clinical labs to identify DNA variants associated with genetic diseases and help direct cancer therapy.

4 unchanged sentences

Arrays can also be customized using the SureDesign software.

In addition to the microarrays, Agilent's solution includes reagents for sample processing, hardware for reading the microarrays, and software to help users view the data in a meaningful way.

In addition to the microarrays, our solution includes reagents for sample processing, hardware for reading the microarrays, and software to help users view the data in a meaningful way.

In addition to the CGH portfolio, the cytogenetics solution comprises a line of oligonucleotide probes for fluorescent in situ hybridization ("FISH") called SureFISH.

Additionally, Agilent provides a wide range of microarrays to the research market for different types of applications:

Additionally, we provide a wide range of microarrays to the research market for different types of applications:

gene expression, microRNA, methylation, splice variants, and chromatin immunoprecipitation applications.

Arrays are offered as catalog designs or customizable designs, with no minimum order size and short delivery time, which differentiates us from other vendors and enables researchers the maximum flexibility in their studies.

PCR and qPCR Instrumentation and Molecular Biology Reagents

Polymerase chain reaction ("PCR") is a standard laboratory method used to amplify the amount of genetic material of a given sample to enable further interrogation.

qPCR Instrumentation and Molecular Biology Reagents

Quantitative PCR ("qPCR") or real time PCR is also a standard method used in genomic research facilities to measure the amount of a specific nucleic acid sequence within a sample.

1 unchanged sentence

among the most common are identifying the expression level of a specific gene or calculating the amount of a specific pathogen present in a sample.

Agilent offers a complete portfolio of qPCR instruments, as well as specialty enzymes for amplifying difficult sample types.

In addition to qPCR enzymes, Agilent offers a wide range of molecular biology reagents including tools for cloning and mutagenesis applications.

We offer a complete portfolio of qPCR instruments, as well as specialty enzymes for amplifying difficult sample types.

In addition to qPCR enzymes, we offer a wide range of molecular biology reagents including tools for cloning and mutagenesis applications.

Nucleic Acid Solutions

Our nucleic acid solutions business is a contract manufacturing and development services business with equipment and expertise focused on mid to large scale production of synthesized oligonucleotide APIs under pharmaceutical GMP conditions for a class of drugs that utilize oligonucleotide molecules for disease therapy.

These drugs have advanced from single strand DNA molecules to complex, highly modified molecules including antisense, aptamers, double-stranded RNA, and RNA mixtures.

These drugs have advanced from single strand DNA molecules to complex, highly modified molecules including antisense, aptamers, double-stranded RNA, and guide RNA.

These advancements in the technology have greatly improved the efficacy of delivery and stability of the oligos in-vivo.

4 unchanged sentences

Prominent examples are nucleic acid preparation products in front of polymerase chain reaction, NGS and microarrays.

More recently, quality control based on automated electrophoresis products has become essential throughout in-vitro transcription ("IVT") mRNA workflows, including vaccine development and therapeutics.

Diagnostics and Genomics Customers

20 unchanged sentences

Abbott Laboratories, Affymetrix, Inc., a division of Thermo Fisher Scientific Inc., Illumina, Inc., Leica Biosystems, Inc., a division of Danaher Corporation, Roche Ventana Medical Systems, Inc., a member of the Roche Group, Avecia, a division of Nitto Denko and Twist Bioscience Corporation.

Agilent competes on the basis of product performance, reliability, support quality, applications expertise, whole solution offering, global channel coverage and price.

We compete on the basis of product performance, reliability, support quality, applications expertise, whole solution offering, global channel coverage and price.

Diagnostics and Genomics Government Regulation

4 unchanged sentences

The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.

The majority of the portfolio is vendor neutral, meaning Agilent can serve customers regardless of their instrument purchase choices.

Services include startup, operational, training and compliance support, software as a service, as well as asset management and consultative services that help increase customer productivity.

Custom service bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

The majority of the portfolio is vendor neutral, meaning we can serve customers regardless of their instrument purchase choices.

The services portfolio includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.

Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.

Our Agilent CrossLab business employed approximately 5,400 people as of October 31, 2023.

Agilent CrossLab Markets

The Pharmaceutical, Biopharmaceutical, CRO & CMO Market .

The Pharmaceutical, Biopharmaceutical, CRO, CDMO & CMO Market .

Our services support customers in this market that consists of “for-profit” companies who participate across the pharmaceutical value chain in the areas of therapeutic research, discovery and development, clinical trials, manufacturing and quality assurance and quality control.

One sub-segment of this market is core and emerging pharmaceutical companies ("pharma").

A second sub-segment includes biopharmaceutical companies ("biopharma"), contract research organizations (" CROs ") and contract manufacturing organizations ("CMOs").

Biopharma companies and, to a somewhat lesser extent, CROs and CMOs typically participate in specific points in the pharmaceutical industry value chain.

A second sub-segment includes biopharmaceutical companies ("biopharma"), contract research organizations (" CROs "), contract development and manufacturing organizations ("CDMOs") and contract manufacturing organizations ("CMOs").

Biopharma companies and, to a somewhat lesser extent, CROs, CDMOs and CMOs typically participate in specific points in the pharmaceutical industry value chain.

Additionally, due to the relatively low drug efficacy within oncology, pharma companies are partnering with diagnostic companies to bring validated tests to the market with their new drugs.

6 unchanged sentences

Chemical market customers use our services, software and technical support to maintain, optimize, and enable higher productivity and profitability for labs, and support quality control and compliance with environmental and safety regulations.

Additionally, our services, software and technical support are used to support the testing for safety, quality, and

compliance across the value chains of advanced materials – including semiconductors, batteries, and specially engineered polymers and polymeric materials .

Additionally, our services, software and technical support are used to support the testing for safety, quality, and compliance across the value chains of advanced materials – including semiconductors, batteries, and specially engineered polymers and polymeric materials .

The natural gas and petroleum exploration and refining markets use our services, software and technical support to support quality control, environmental safety reviews, analysis of crude oil composition, and improve their refining processes and quality of products.

16 unchanged sentences

As customers continue to outsource laboratory operations and consolidate suppliers, our enterprise services consist of a broad portfolio of integrated laboratory management services including instrument services, lab supply management, asset management, procurement, informatics and scientific services.

Advancements in our offering software and service solutions will help our customers operate a more digitally connected smart lab that can derive more value out of data analytics, artificial intelligence and robotics.

Advancements in our offering software and service solutions will help our customers more efficiently operate a more digitally connected smart lab that can derive more value out of data analytics, artificial intelligence and robotics.

Agilent CrossLab Customers

12 unchanged sentences

In addition to the traditional telephone support and on-site service, our teams remotely engage customers through various digital tools and omni-channel platforms.

We also offer special industry-focused service bundles that are designed to meet the specific needs of pharmaceutical and

biopharmaceutical, advanced materials, environmental and hydrocarbon processing customers to keep instruments fully operational and compliant with the respective industry requirements.

We also offer special industry-focused service bundles that are designed to meet the specific needs of pharmaceutical and biopharmaceutical, advanced materials, environmental and hydrocarbon processing customers to keep instruments fully operational and compliant with the respective industry requirements.

Our products typically come with standard warranties, and extended warranties are available for additional cost.

5 unchanged sentences

and Waters Corporation, as well as numerous niche service providers.

Agilent competes on the basis of reliability, support quality, applications expertise, global channel coverage and price.

We compete on the basis of reliability, support quality, applications expertise, global channel coverage and price.

Agilent Technologies Research Laboratories

Agilent Technologies Research Laboratories ("Agilent Labs") is our central research organization based in Santa Clara, California.

The Research Labs create competitive advantage through high-impact technology, driving market leadership and growth in Agilent's core businesses and expanding Agilent's footprint into adjacent markets.

At the cross-roads of the organization, the Research Labs are able to identify and enable synergies across Agilent's businesses to create competitive differentiation and compelling customer value.

Agilent Labs create competitive advantage through high-impact technology, driving market leadership and growth in our core businesses and expanding Agilent's footprint into adjacent markets.

At the cross-roads of the organization, the Agilent Labs are able to identify and enable synergies across our businesses to create competitive differentiation and compelling customer value.

The technical staff have advanced degrees that cover a wide range of scientific and engineering fields, including molecular and cell biology, chemistry, physics, pathology, mathematics, software and informatics, artificial intelligence, deep and machine learning, image processing, nano/microfabrication, and fluidics.

38 unchanged sentences

In addition to monitoring and managing compliance with environmental regulations, we are also committed to sustainability and environmental protection.

In 2021, we announced our commitment to achieve net-zero greenhouse gas emissions no later than 2050.

In 2021, we committed to achieve net-zero greenhouse gas emissions no later than 2050.

As part of our climate action plan, we have established near and long term emission reduction targets to limit planetary

warming to 1.5 °C above pre-industrial levels which have been approved by the Science Based Targets initiative ("SBTi").

For more information on our approach to sustainability management, refer to our 2022 ESG report, which is available on our website.

13 unchanged sentences

In Europe, the European Union has started to enforce new requirements, known as the EU In Vitro Diagnostic Regulation (“EU IVDR”), which imposes stricter requirements for the marketing and sale of in vitro diagnostics in the European Union.

regulations are more stringent in a variety of areas, including clinical requirements, quality systems and post-market surveillance activities.

These new regulations are more stringent in a variety of areas, including clinical requirements, quality systems and post-market surveillance activities.

The new EU IVDR requirements became effective starting in May 2022.

14 unchanged sentences

We also leverage temporary workers to provide flexibility for our business and manufacturing needs.

Agilent instruments, software, services, solutions and people provide trusted answers to customers’ most challenging questions.

Whether we are working with our customers to keep food supplies safe, improve the quality of air, water and soil, or fight cancer with more precise diagnoses and targeted treatments, Agilent employees share a passion and commitment to advancing the quality of life.

We believe that our future success largely depends upon our continued ability to attract and retain highly skilled employees in order to fulfil that commitment.

Agilent engages with our employees through consultation, surveys, ad-hoc feedback and reviews.

Our instruments, software, services, solutions and people provide trusted answers to customers’ most challenging questions.

advancing the quality of life.

We believe that our future success largely depends upon our continued ability to attract and retain highly skilled employees in order to fulfill that commitment.

We engage with our employees through consultation, surveys, ad-hoc feedback and reviews.

Our executive officers hold all-managers meetings on a quarterly basis to provide business updates and answer questions.

9 unchanged sentences

As of October 31, 2023, approximately 38 percent of our full-time employees were female.

Approximately 42

percent of our board is comprised of directors representing underrepresented groups as of the date of this report.

Approximately 42 percent of our board is comprised of directors representing underrepresented groups as of the date of this report.

We have launched a number of company-wide initiatives including employee-network groups aimed at promoting engagement of traditionally underrepresented groups of employees.

12 unchanged sentences

The health and safety of our employees is a top priority for us.

Our environmental, health and safety management system provides a framework for assessing and managing risks relating to health and safety.

Our environmental, health and safety ("EHS") management system provides a framework for assessing and managing risks relating to health and safety.

We ensure managers and employees receive periodic workplace safety training and provide wellness programs that contribute to the productivity, health, and well-being of employees.

In addition, our crisis management program includes a global tool that enables us to reach, locate and support employees in travel or in crisis areas.

We regularly evaluate and review with senior management the performance of our programs and processes.

In response to the COVID-19 pandemic, we took proactive actions to protect the health and safety of our employees, customers, partners and suppliers.

In the U.S., we enacted safety measures, including social distancing protocols, encouraging employees to work from home when possible, suspending non-essential work travel, implementing various access controls at our facilities, frequently disinfecting our workspaces and providing appropriate personal protective equipment to employees who are physically present at our facilities.

As COVID-19 conditions improved, we implemented a phased reopening process and continued to prioritize health and safety.

We expect to continue to implement appropriate safety measures as necessary, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers, partners and suppliers.

Each year Agilent employees throughout the world devote thousands of volunteer hours to community service activities.

Each year our employees throughout the world devote thousands of volunteer hours to community service activities.

Our employees may take up to six days of paid time off each year for volunteer activities with charities and organizations.

2 unchanged sentences

The names of our current executive officers and their ages, titles and biographies appear below:

Henrik Ancher-Jensen, 57, has served as our Senior Vice President, Agilent and President, Order Fulfillment since September 2013.

Henrik Ancher-Jensen, 58, has served as our Senior Vice President, Agilent and President, Order Fulfillment and Supply chain since September 2013.

From September 2012 to September 2013, Mr.

3 unchanged sentences

Hansen, Deloitte Consulting and NVE.

Phil Binns, 62, has served as our Senior Vice President, Agilent and President, Life Sciences and Applied Markets Group since September 2023.

From January 2015 to September 2023, Mr.

Binns served as Agilent Vice President and General Manager for the Spectroscopy and Vacuum Products Division.

From 2010 to January 2015, Mr Binns served as Agilent Vice President and General Manager for the Spectroscopy Division.

Prior to joining Agilent in 2010, he held various positions in Varian’s global operations since 1994, including his appointment as General Manager of Varian’s field operations in 2004 for the Pacific Rim.

Rodney Gonsalves, 58, has served as our Vice President, Corporate Controllership and Chief Accounting Officer since May 2015.

20 unchanged sentences

McMahon spent 20 years with Johnson & Johnson most recently as Worldwide Vice President of Finance and Business Development for Ortho Clinical Diagnostics a division of Johnson & Johnson's Medical Device and Diagnostics Group.

Since July 2023, Mr.

McMahon has served as a member of the Board of Directors of Orasure Technologies, Inc.

McMullen , 62, has served as Chief Executive Officer since March 2015 and as President since September 2014.

4 unchanged sentences

McMullen served as Controller for the Hewlett‑Packard Company and Yokogawa Electric Joint Venture from July 1996 to March 1999.

Since September 2018, Mr.

McMullen has served as a member of the Board of Directors of Coherent, Inc.

Raha , 50, has served as our Senior Vice President, Agilent and President, Diagnostics and Genomics Group since April 2018.

From May 2017 to April 2018, Mr.

Raha served as our Senior Vice President, Strategy and Corporate Development.

From June 2013 to January 2017 he served as Vice President, Global Marketing for Illumina, Inc.

and from 2008 to 2012 he served as Vice President and General Manager, Genomic Assays / NextGen qPCR for Life Technologies, Inc.

From September 2018 to July 2022, Mr.

McMullen served as a member of the Board of Directors of Coherent, Inc.

Since July 2023, Mr.

McMullen has served as a member of the Board of Directors of KLA Corporation.

Michael Tang, 49, has served as our Senior Vice President, General Counsel and Secretary since January 2016.

5 unchanged sentences

Tang worked at Wilson Sonsini Goodrich & Rosati, a California law firm and Fenwick & West LLP, a California law firm.

Jacob Thaysen , 47, has served as our Senior Vice President, Agilent and President, Life Sciences and Applied Markets Group, since April 2018.

From November 2014 to April 2018 he served as Senior Vice President, Agilent and President, Diagnostics and Genomics Group.

From October 2013 to November 2014 he served as Vice President and General Manager of the Diagnostics and Genomics business.

Prior to that he served as Vice President and General Manager of the Genomics Solutions unit from January 2013 to October 2013.

Before joining Agilent, he served in various capacities at Dako A/S, a Danish diagnostics company, including as Corporate Vice President of R&D, Vice President, System Development, R&D, Vice President, Strategic Marketing and Vice President, Global Sales Operations.

Prior to Dako, Mr.

Thaysen worked as a management consultant and Chief Technical Officer and founder of a high-tech start-up company.

Investor Information

4 unchanged sentences

The address is www.investor.agilent.com.

of the Exchange Act as soon as reasonably practicable after filing such material electronically or otherwise furnishing it to the SEC.

We make available, free of charge, copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after filing such material electronically or otherwise furnishing it to the SEC.

Our Amended and Restated Bylaws, Corporate Governance Standards, the charters of our Audit and Finance Committee, our Compensation Committee, our Executive Committee and our Nominating/Corporate Governance Committee, as well as our Standards of Business Conduct (including code of ethics provisions that apply to our principal executive officer, principal financial officer, principal accounting officer and senior financial officers) are available on our website at www.investor.agilent.com under “Corporate Governance”.

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 1. Business